Company History
Our journey since 2022
Founded in 2022 with the objective of developing pharmaceutical manufacturing capabilities in Afghanistan, TJL has developed step by step. Milestones marked 'to be confirmed' await management verification.
2022
Company Establishment
Founding of TJL Pharmaceuticals in Kabul with the objective of developing pharmaceutical manufacturing capabilities and supporting the healthcare sector.
2023
Business Development
Operational developments, infrastructure investment and business milestones — details to be confirmed by management.
2024
Manufacturing Development
Production, facility and equipment milestones — details to be confirmed by management.
2025
Operational Growth
Product development and business expansion milestones — details to be confirmed by management.
2026
Current Operations & Future Direction
Manufacture of the LifeSol® IV solutions range, an international branch network, and preparation for the IV sets & syringes product line launching 1 January 2027.
Milestones marked 'to be confirmed' will be updated as soon as they are verified and approved by company management. Contact us